Lipoprotein(a) Clinical Trials in Budapest
2 recruitingBudapest, Hungary
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263
Recruiting
Cardiovascular Risk in Children With Chronic Conditions Study
Obesity and OverweightLymphomaLeukemia+22 more
Semmelweis University300 enrolled3 locationsNCT07086989